Acasti Pharma Inc. ACST
3.37 +3.37
Day range unavailable
52-week range unavailable
News
businesswire.com ACS Technologies and the Evangelical Lutheran Church in America Expand Strategic Partnership to Deliver a Connected Ministry Experience FLORENCE, S.C.--(BUSINESS WIRE)-- #churchpayments--ACS Technologies (ACST), powered by Vanco, today announced the expansion of its strategic relationship with the Evangelical Lutheran Church in…
businesswire.com Vanco, ACS Technologies, and GCFA Strengthen Partnership Through Expanded Ministry Ecosystem FLORENCE, S.C.--(BUSINESS WIRE)-- #churchchms--Vanco, ACS Technologies (ACST), and the General Council on Finance and Administration (GCFA) are strengthening their partnership through an expanded…
globenewswire.com Acasti Announces Corporate Name Change to Grace Therapeutics, Inc. Name Change Reflects Extensive Scientific and Corporate Brand Equity Previously Established under Grace Therapeutics Grace Therapeutics will begin trading on Nasdaq under the trading symbol "GRCE"…
globenewswire.com Acasti Announces Completion of Patient Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial of GTX-104 Data Readout Expected Early Calendar 2025; NDA Submission on Track for 1H Calendar 2025 Data Readout Expected Early Calendar 2025; NDA Submission on Track for 1H Calendar 2025
globenewswire.com Acasti to Participate in the H.C. Wainwright 26th Annual Global Investment Conference PRINCETON, N.J., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel injectable formulation of…
globenewswire.com Acasti Announces First Fiscal Quarter 2025 Financial Results, Provides Business Update PRINCETON, N.J., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel injectable formulation of…
zacks.com Is Acasti Pharma (ACST) Outperforming Other Medical Stocks This Year? Here is how Acasti Pharma (ACST) and Cigna (CI) have performed compared to their sector so far this year.
globenewswire.com Acasti Announces Achievement of 50% Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial Company Anticipates Completion of Patient Enrollment in the STRIVE-ON Trial in Late 2024 to Early 2025, with Potential NDA Submission on Track for 1H Calendar 2025 Company Anticipates Completion of…
globenewswire.com Acasti Announces Year-End 2024 Financial Results, Provides Business Update PRINCETON, N.J., June 21, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel injectable formulation of…
investorplace.com Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for June 2024 As the main stock indices like the S&P 500 and Nasdaq continue to climb, penny stocks are becoming attractive for those seeking significant returns. Despite their reputation for extreme price…
globenewswire.com Acasti Pharma to Attend BIO International Convention 2024 PRINCETON, N.J., May 28, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel, injectable formulation of…
investorplace.com The Next Novavax? 3 Biopharma Stocks to Buy Before They Boom Novavax (NASDAQ: NVAX ) stock was among the laggards in the race for the vaccine against COVID-19. Unsurprisingly, NVAX stock plunged from highs of $320 in 2021 to recent lows of $3.5.
globenewswire.com Acasti Announces Third Fiscal Quarter 2024 Financial Results and Business Highlights PRINCETON, N.J., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel formulation of nimodipine…
globenewswire.com Acasti Announces Poster Detailing its GTX-104 STRIVE-ON Trial Accepted for Presentation at the 2024 International Stroke Conference Accepted for Presentation at the 2024 International Stroke Conference
benzinga.com Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session Shares of KeyCorp (NYSE: KEY) moved lower during Thursday’s session after the company reported fourth-quarter financial results. Revenues of $1.538 billion, down 19.0% Y/Y, slightly topped the…
globenewswire.com Acasti to Participate in Upcoming San Francisco Investor Conferences in January 2024 PRINCETON, N.J., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel intravenous formulation of…
globenewswire.com Acasti Announces Second Quarter 2024 Financial Results and Business Highlights PRINCETON, N.J., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel formulation of nimodipine…
globenewswire.com Acasti Announces Dosing of First Patient in GTX-104 STRIVE-ON Trial PRINCETON, N.J., Oct. 23, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel formulation of nimodipine…
globenewswire.com Acasti Pharma to Host KOL Event on GTX-104: A Potential New Treatment Standard for Rare and Life-Threatening aneurysmal Subarachnoid Hemorrhage (aSAH) PRINCETON, N.J., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel formulation of nimodipine…
globenewswire.com Acasti Announces $7.5 Million Private Placement Equity Financing PRINCETON, N.J., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel formulation of nimodipine…
globenewswire.com Acasti to Participate in the H.C. Wainwright Global Investment Conference PRINCETON, N.J., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel formulation of nimodipine…
benzinga.com Earnings Scheduled For February 14, 2023 Companies Reporting Before The Bell • WESCO International (NYSE:WCC) is projected to report quarterly earnings at $3.79 per share on revenue of $5.37 billion.
benzinga.com Why Graphite Bio Shares Are Trading Lower By 50%; Here Are 20 Stocks Moving Premarket Gainers OncoCyte Corporation (NASDAQ: OCX) rose 89.2% to $0.70 in pre-market trading. Oncocyte, last month, announced an over 40% reduction of its workforce to realign the team towards key products…
benzinga.com Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session Gainers- benzinga.com Why IceCure Medical Shares Are Trading Higher By 296%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 296% to $3.71 after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who…
benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022 
benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022 
benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 127 companies set new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Wednesday Wednesday saw 219 companies set new 52-week lows.
benzinga.com Earnings Scheduled For November 14, 2022 Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 63 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday During Monday's session, 101 companies made new 52-week lows.
- benzinga.com 121 Stocks That Hit Their 52-Week Low New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 121 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday During Friday's session, 574 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 297 companies achieved new lows for the year.
- benzinga.com Earnings Scheduled For August 11, 2022 Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.
- benzinga.com 20 Stocks Moving in Monday's Pre-Market Session Gainers Decisionpoint Systems, Inc. (NASDAQ: DPSI) shares rose 32.3% to $8.85 in pre-market trading after declining over 4% on Friday.
- benzinga.com Earnings Scheduled For February 14, 2022 Companies Reporting Before The Bell • Weber (NYSE:WEBR) is projected to report quarterly loss at $0.06 per share on revenue of $310.78 million.
- benzinga.com 50 Biggest Movers From Yesterday Gainers Society Pass Incorporated (NASDAQ: SOPA) shares surged 53.4% to settle at $16.31 on Wednesday.
- benzinga.com Earnings Scheduled For November 10, 2021 Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.24 per share on revenue of $94.32 million.
- benzinga.com 45 Biggest Movers From Yesterday Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares surged 44.8% to close at $6.50 on Wednesday after the company reported topline Phase 2 bone mineral density data for EB613.
benzinga.com 31 Stocks Moving In Wednesday's Mid-Day Session Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares jumped 58% to $7.09 after the company reported topline Phase 2 bone mineral density data for EB613.- benzinga.com 26 Stocks Moving in Wednesday's Pre-Market Session Gainers Acasti Pharma Inc. (NASDAQ: ACST) rose 39% to $0.75 in pre-market trading after jumping 10% on Tuesday. The company reported a narrower FY21 loss.
- benzinga.com 38 Stocks Moving in Tuesday's Pre-Market Session Gainers INVO Bioscience, Inc. (NASDAQ: INVO) shares rose 108.4% to $6.48 in pre-market trading after the company announced an amendment under its exclusive U.S. commercialization agreement with…
- benzinga.com Stocks That Hit 52-Week Highs On Wednesday This morning 533 companies reached new 52-week highs.
- benzinga.com 70 Stocks Moving In Thursday's Mid-Day Session Gainers JanOne Inc. (NYSE: JAN) shares jumped 175.5% to $26.25 amid continued momentum driven by retail investor interest in the stock.
- benzinga.com 45 Stocks Moving in Thursday's Pre-Market Session Gainers JanOne Inc. (NASDAQ: JAN) shares rose 154.8% to $24.26 in pre-market trading after climbing around 48% on Wednesday.
- benzinga.com Stocks That Hit 52-Week Highs On Thursday During Thursday's morning trading, 190 companies set new 52-week highs.
- benzinga.com 40 Stocks Moving in Wednesday's Pre-Market Session Gainers Ocugen, Inc. (NASDAQ: OCGN) shares rose 75.1% to $1.41 in pre-market trading. Ocugen shares jumped around 174% on Tuesday after the company and Bharat Biotech announced plans to co-develop a…
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday During Wednesday's morning trading, 129 companies set new 52-week lows. Areas of Interest: The largest company in terms of market cap to set a new 52-week low was Wells Fargo (NYSE: WFC).